Introduction
Canada has a rapidly growing MedTech ecosystem with manufacturers developing advanced connected medical devices, Software as a Medical Device (SaMD), AI-driven healthcare solutions and cloud-connected platforms. Many Canadian medical device companies are expanding globally and targeting the European market. However, entry into Europe requires compliance with the European Union Medical Device Regulation (EU MDR 2017/745).
EU MDR places strong emphasis on cybersecurity as a core component of patient safety. Manufacturers must demonstrate that medical devices are protected against cyber threats throughout the entire product lifecycle. Vulnerability Assessment and Penetration Testing (VAPT) is therefore a critical requirement for CE marking and regulatory approval.
Cyberintelsys helps Canadian medical device manufacturers achieve EU MDR readiness by delivering specialized VAPT services designed to strengthen security, reduce regulatory risk and accelerate market access.
EU MDR Cybersecurity Requirements
EU MDR 2017/745 introduces a lifecycle-based regulatory framework that significantly strengthens safety, risk management and post-market monitoring requirements for medical devices sold in Europe.
Cybersecurity expectations under EU MDR include:
1. Secure Device Design
Medical devices must be designed to prevent unauthorized access, misuse, or manipulation.
2. Lifecycle Risk Management
Cybersecurity risks must be integrated into ISO 14971 risk management processes.
3. Protection of Patient Data and Device Integrity
Manufacturers must protect:
Patient health data
Device functionality and safety
Communication channels and software updates
4. Secure Software Development
EU MDR requires:
Secure coding practices
Vulnerability monitoring
Patch management processes
Incident response planning
5. Post-Market Cybersecurity Monitoring
Manufacturers must continuously monitor vulnerabilities and respond to emerging threats.
For Canadian manufacturers targeting Europe, demonstrating security testing through VAPT is essential to pass Notified Body assessments and achieve CE marking.
Importance of EU MDR VAPT for Canadian Medical Device Manufacturers
1. CE Marking Readiness
Notified Bodies require strong cybersecurity testing evidence within technical documentation.
2. Increasing Threat Landscape
Healthcare organizations are a prime target for ransomware and cyberattacks.
3. Safety and Patient Trust
Cybersecurity failures can lead to device malfunction or data breaches.
4. Avoiding Certification Delays
Security testing early in the development lifecycle reduces rework and redesign costs.
5. Global Market Expansion
EU MDR readiness opens opportunities for expansion into multiple international markets.
Our Methodology – EU MDR Medical Device VAPT
Cyberintelsys follows a structured methodology aligned with EU MDR lifecycle cybersecurity expectations.
1. EU MDR Cybersecurity Gap Assessment
Evaluation of existing cybersecurity controls and documentation readiness.
2. Threat Modeling and Risk Analysis
Identification of device-specific threats based on architecture, connectivity and usage scenarios.
3. Vulnerability Assessment
Automated and manual testing to identify weaknesses in:
Firmware and operating systems
APIs and communication protocols
Cloud infrastructure and backend systems
4. Penetration Testing
Simulation of real-world attacks targeting:
Embedded medical devices
Cloud environments
Authentication and encryption mechanisms
5. Secure Configuration Review
Assessment of device hardening, encryption and update mechanisms.
6. Remediation and Retesting
Validation of implemented security fixes before regulatory submission.
7. Compliance Documentation Support
Preparation of VAPT reports aligned with EU MDR expectations for Notified Body review.
Cyberintelsys EU MDR VAPT Services
Cyberintelsys provides end-to-end security testing services tailored for Canadian MedTech companies.
1. Medical Device Penetration Testing
Includes:
Embedded device testing
Firmware analysis
Wireless protocol security testing
Hardware interface testing
2. SaMD Security Testing
Includes:
Secure code review
API and backend testing
Authentication and authorization testing
Encryption validation
3. Mobile Healthcare Application Testing
Includes:
Android and iOS security testing
Reverse engineering testing
Secure storage and data protection validation
4. Cloud & Backend Security Testing
Includes:
Cloud configuration reviews
Infrastructure penetration testing
Container and microservices security testing
5. EU MDR Documentation Support
Deliverables include:
VAPT reports aligned with MDR expectations
Risk mitigation guidance
Evidence for regulatory submissions
Why Choose Cyberintelsys
Cyberintelsys is a CREST-accredited cybersecurity company for Vulnerability Assessment (VA) and Penetration Testing (PT), delivering industry-recognized security testing services for organizations across multiple sectors.
1. Medical Device Security Expertise
Extensive experience testing connected healthcare ecosystems.
2. EU MDR-Aligned Testing Approach
Testing aligned with EU MDR lifecycle requirements and regulatory expectations.
3. End-to-End Support
From gap assessments to remediation validation and documentation support.
4. Accelerated CE Marking Readiness
Security testing integrated into development to reduce certification delays.
5. Global Market Enablement
Helping Canadian medical device manufacturers expand into Europe with confidence.
Begin Your EU MDR Cybersecurity Journey with Cyberintelsys
Cybersecurity is now a mandatory requirement for medical device manufacturers entering the European market. EU MDR requires continuous risk management, security testing and lifecycle monitoring.
Cyberintelsys helps Canadian MedTech organizations strengthen security, prepare for regulatory audits and achieve EU MDR readiness with confidence.
Contact Cyberintelsys today to strengthen your medical device cybersecurity and accelerate EU MDR compliance.
